Allergic Contact Dermatitis in Pediatric Practice


Цитировать

Полный текст

Аннотация

Background:Allergic contact dermatitis (ACD) is prevalent among pediatric population, adolescent and young adults. Patients with ACD experience a lot of sociopsychological and quality-of-life (QoL) difficulties. Children and their caregivers alike are vulnerable to the burden of ACD.

Objective:We have, in this paper, provided an overview of ACD and discussed common and unu-sual causes of ACD.

Methods:We performed an up-to-date literature review in the English language on "allergic contact dermatitis" via PubMed Clinical Queries, using the keywords "allergic contact dermatitis" in Au-gust 2022. The search included meta-analyses, randomized controlled trials, clinical trials, case-control studies, cohort studies, observational studies, clinical guidelines, case series, case reports, and reviews. The search was restricted to English literature and children.

Results:ACD may be acute or chronic and it affects more than 20% of children and adults with significant quality-of-life impairments. ACD is manifested by varying degrees of cutaneous edema, vesiculation, and erythema. The hypersensitivity reaction is one of the most prevalent forms of im-munotoxicity in humans. Localized acute ACD lesions can be managed with high-potency topical steroids; if ACD is severe or extensive, systemic corticosteroid therapy is often required to provide relief within 24 hours. In patients with more severe dermatitis, oral prednisone should be tapered over 2-3 weeks. Rapid discontinuation of corticosteroids can result in rebound dermatitis. Patch testing should be performed if treatment fails and the specific allergen or diagnosis remains un-known.

Conclusion:ACD is common and can be a physically, psychologically, and economically burden-some disease. Diagnosis of ACD is primarily based on history (exposure to an allergen) and physi-cal examination (morphology and location of the eruption). Skin patch test can help determine the causative allergen. Allergen avoidance is the cornerstone of management. Topical mid- or high-potency corticosteroids are the mainstay of treatment for lesions on less than 20% of the body area. Severe cases of ACD may require treatment with systemic corticosteroids.

Об авторах

Kam Hon

Department of Paediatrics, CUHKMC, The Chinese University of Hong Kong, Hong Kong,

Автор, ответственный за переписку.
Email: info@benthamscience.net

Alexander Leung

Department of Pediatrics, The University of Calgary, The Alberta Children’s Hospital

Email: info@benthamscience.net

James Cheng

Department of Paediatrics and Adolescent Medicine, United Christian Hospital

Email: info@benthamscience.net

David Luk

Department of Paediatrics and Adolescent Medicine, United Christian Hospital

Email: info@benthamscience.net

Agnes Leung

Department of Paediatrics, Prince of Wales Hospital,, The Chinese University of Hong Kong

Email: info@benthamscience.net

Mark Koh

Department of Dermatology, KK Women's and Children's Hospital

Email: info@benthamscience.net

Список литературы

  1. American Academy of Allergy, Asthma, and Immunology. Skin Allergy Symptoms, Diagnosis, Treatment & Management. 2020. Available From: https://www.aaaai.org/conditions-and-treatments/allergies/skin-allergy
  2. Leung AKC, Hon KLE, Robson WLM. Atopic Dermatitis. Adv Pediatr 2007; 54(1): 241-73. doi: 10.1016/j.yapd.2007.03.013 PMID: 17918474
  3. Antia C, Baquerizo K, Korman A, Alikhan A, Bernstein JA. Urticaria: A comprehensive review. J Am Acad Dermatol 2018; 79(4): 617-33. doi: 10.1016/j.jaad.2018.01.023 PMID: 30241624
  4. Hon KL, Leung AKC, Ng WGG, Loo SK. Chronic urticaria: An overview of treatment and recent patents. Recent Pat Inflamm Allergy Drug Discov 2019; 13(1): 27-37. doi: 10.2174/1872213X13666190328164931 PMID: 30924425
  5. Grob JJ, Gaudy-Marqueste C. Urticaria and quality of life. Clin Rev Allergy Immunol 2006; 30(1): 047-52. doi: 10.1385/CRIAI:30:1:047 PMID: 16461995
  6. Kimber I, Basketter DA, Gerberick GF, Dearman RJ. Allergic contact dermatitis. Int Immunopharmacol 2002; 2(2-3): 201-11. doi: 10.1016/S1567-5769(01)00173-4 PMID: 11811925
  7. Nassau S, Fonacier L. Allergic contact dermatitis. Med Clin North Am 2020; 104(1): 61-76. doi: 10.1016/j.mcna.2019.08.012 PMID: 31757238
  8. Bains SN, Nash P, Fonacier L. Irritant contact dermatitis. Clin Rev Allergy Immunol 2019; 56(1): 99-109. doi: 10.1007/s12016-018-8713-0 PMID: 30293200
  9. Nosbaum A, Vocanson M, Rozieres A, Hennino A, Nicolas JF. Allergic and irritant contact dermatitis. Eur J Dermatol 2009; 19(4): 325-32. doi: 10.1684/ejd.2009.0686 PMID: 19447733
  10. Li Y, Li L. Contact dermatitis: Classifications and management. Clin Rev Allergy Immunol 2021; 61(3): 245-81. doi: 10.1007/s12016-021-08875-0 PMID: 34264448
  11. Neale H, Garza-Mayers AC, Tam I, Yu J. Pediatric allergic contact dermatitis. Part I: Clinical features and common contact allergens in children. J Am Acad Dermatol 2021; 84(2): 235-44. doi: 10.1016/j.jaad.2020.11.002 PMID: 33217510
  12. Tam I, Yu J. Pediatric contact dermatitis: What’s new. Curr Opin Pediatr 2020; 32(4): 524-30. doi: 10.1097/MOP.0000000000000919 PMID: 32618793
  13. Dupuy E, Miller M, Harter N. What we have learned-milestones in pediatric contact dermatitis. Curr Dermatol Rep 2022; 11(1): 1-12. doi: 10.1007/s13671-022-00353-w PMID: 35369649
  14. Sharma V, Asati D. Pediatric contact dermatitis. Indian J Dermatol Venereol Leprol 2010; 76(5): 514-20. doi: 10.4103/0378-6323.69070 PMID: 20826990
  15. Belloni Fortina A, Caroppo F, Tadiotto Cicogna G. Allergic contact dermatitis in children. Expert Rev Clin Immunol 2020; 16(6): 579-89. doi: 10.1080/1744666X.2020.1777858 PMID: 32490693
  16. Murphy PB, Atwater AR, Mueller M. Allergic contact dermatitis. JAMA 2021; 157(3): 364.
  17. Peiser M, Tralau T, Heidler J, et al. Allergic contact dermatitis: Epidemiology, molecular mechanisms, in vitro methods and regulatory aspects. Cell Mol Life Sci 2012; 69(5): 763-81. doi: 10.1007/s00018-011-0846-8 PMID: 21997384
  18. Nguyen SH, Dang TP, MacPherson C, Maibach H, Maibach HI. Prevalence of patch test results from 1970 to 2002 in a multi-centre popu-lation in North America (NACDG). Contact Dermat 2008; 58(2): 101-6. doi: 10.1111/j.1600-0536.2007.01281.x PMID: 18186744
  19. Kohl L, Blondeel A, Song M. Allergic contact dermatitis from cosmetics. Retrospective analysis of 819 patch-tested patients. Dermatology 2002; 204(4): 334-7. doi: 10.1159/000063379 PMID: 12077541
  20. Lunder T, Kansky A. Increase in contact allergy to fragrances: Patch-test results 1989-1998. Contact Dermat 2000; 43(2): 107-9. doi: 10.1034/j.1600-0536.2000.043002107.x PMID: 10945750
  21. Ljubojević Hadžavdić S, Pustišek N, Žužul K, Švigir A. Contact allergy: An update. Ital J Dermatol Venereol 2018; 153(3): 419-28. doi: 10.23736/S0392-0488.17.05844-8 PMID: 29199804
  22. Warshaw EM, Shaver RL, DeKoven JG, et al. Patch test reactions associated with topical medications: A retrospective analysis of the North American Contact Dermatitis Group Data (2001-2018). Dermatitis 2022; 33(2): 144-54. doi: 10.1097/DER.0000000000000777 PMID: 34405832
  23. Wennervaldt M, Ahlström MG, Menné T, et al. Chromium and cobalt release from metallic earrings from the Danish market. Contact Dermat 2021; 85(5): 523-30. doi: 10.1111/cod.13917 PMID: 34148232
  24. Slodownik D, Rabah S, Levi A, et al. The relationship between atopy and allergic contact dermatitis in Israeli patients. Postepy Dermatol Alergol 2022; 39(1): 159-63. doi: 10.5114/ada.2022.113606 PMID: 35369630
  25. Rodrigues DF, Marcos EMA. Patch-test results in children and adolescents: Systematic review of a 15-year period. An Bras Dermatol 2016; 91: 64-72.
  26. Cai X, Smirnova L, Ma Z, Orlova E. Allergic contact dermatitis and associated allergic dermatoses: Epidemiological, allergic, and immunological characteristics. Postepy Dermatol Alergol 2021; 38(6): 1058-64. doi: 10.5114/ada.2021.104692 PMID: 35126015
  27. Seine AJ, Baird EA, Chan L, et al. A baseline patch test series for New Zealand. Australas J Dermatol 2021; 62(4): 489-95. doi: 10.1111/ajd.13673 PMID: 34293187
  28. Lee EY, Wee CLP, Tan CH, et al. Pediatric patch testing in a multi‐ethnic Asian population: A retrospective review. Pediatr Dermatol 2022; 39(1): 69-76. doi: 10.1111/pde.14904 PMID: 34971009
  29. Jacob SE, Herro EM, Sullivan SE, Matiz C, Eichenfield L, Hamann C. Safety and efficacy evaluation of TRUE TEST panels 1.1, 2.1, and 3.1 in children and adolescents. Dermatitis 2011; 22(4): 204-10.
  30. Kundak S. Patch test results of contact sensitization in children without atopic dermatitis: A single tertiary center experience. Dermatitis 2020; 31(2): 153-6. doi: 10.1097/DER.0000000000000530 PMID: 31609858
  31. Yılmaz Z, Özkaya E. Patch test results in terms of the recently recommended allergens in children and adolescents: A retrospective cohort study over 22 years from Turkey. Contact Dermat 2021; 85(2): 198-210. doi: 10.1111/cod.13842 PMID: 33759232
  32. Lee PW, Elsaie ML, Jacob SE. Allergic contact dermatitis in children: Common allergens and treatment: A review. Curr Opin Pediatr 2009; 21(4): 491-8. doi: 10.1097/MOP.0b013e32832d2008 PMID: 19584724
  33. Neale H, Garza-Mayers AC, Tam I, Yu J. Pediatric allergic contact dermatitis. Part 2: Patch testing series, procedure, and unique scenarios. J Am Acad Dermatol 2021; 84(2): 247-55. doi: 10.1016/j.jaad.2020.11.001 PMID: 33217511
  34. Thyssen JP, Linneberg A, Menné T, Johansen JD. The epidemiology of contact allergy in the general population - prevalence and main findings. Contact Dermat 2007; 57(5): 287-99. doi: 10.1111/j.1600-0536.2007.01220.x PMID: 17937743
  35. Ng A, Atwater AR, Reeder M. Contact allergy to topical medicaments, Part 2: Steroids, immunomodulators, and anesthetics, Oh My! Cutis 2022; 109(1): 36-9. doi: 10.12788/cutis.0436 PMID: 35180054
  36. Geier J, Ballmer-Weber B, Buhl T, et al. Is benzyl alcohol a significant contact sensitizer? J Eur Acad Dermatol Venereol 2022; 36(6): 866-72. doi: 10.1111/jdv.17968 PMID: 35080274
  37. Nguyen HL, Yiannias JA. Contact dermatitis to medications and skin products. Clin Rev Allergy Immunol 2019; 56(1): 41-59. doi: 10.1007/s12016-018-8705-0 PMID: 30145645
  38. Mortz CG, Lauritsen JM, Bindslev-Jensen C, Andersen KE. Contact allergy and allergic contact dermatitis in adolescents: Prevalence measures and associations. Acta Derm Venereol 2002; 82(5): 352-8. doi: 10.1080/000155502320624087 PMID: 12430734
  39. Leonard A, Guttman-Yassky E. Unique molecular signatures of contact dermatitis and implications for treatment. Clin Rev Allergy Immunol 2019; 56(1): 1-8. doi: 10.1007/s12016-018-8685-0 PMID: 29754191
  40. Dhingra N, Shemer A, Correa da Rosa J, et al. Molecular profiling of contact dermatitis skin identifies allergen-dependent differences in immune response. J Allergy Clin Immunol 2014; 134(2): 362-72. doi: 10.1016/j.jaci.2014.03.009 PMID: 24768652
  41. White SI, Friedmann PS, Moss C, Simpson JM. The effect of altering area of application and dose per unit area on sensitization by DNCB. Br J Dermatol 1986; 115(6): 663-8. doi: 10.1111/j.1365-2133.1986.tb06646.x PMID: 3801307
  42. Iwasaki A. Local advantage: skin DCs prime; skin memory T cells protect. Nat Immunol 2009; 10(5): 451-3. doi: 10.1038/ni0509-451 PMID: 19381136
  43. Luo Y, Zhu Z, Li B, et al. Keratin 17 Promotes T Cell Response in Allergic Contact Dermatitis by Upregulating C-C Motif Chemokine Ligand 20. Front Immunol 2022; 13764793 doi: 10.3389/fimmu.2022.764793 PMID: 35178048
  44. Czarnobilska E, Obtulowicz K, Dyga W, Wsolek-Wnek K, Spiewak R. Contact hypersensitivity and allergic contact dermatitis among school children and teenagers with eczema. Contact Dermat 2009; 60(5): 264-9. doi: 10.1111/j.1600-0536.2009.01537.x PMID: 19397618
  45. Belhadjali H, Mohamed M, Youssef M, Mandhouj S, Chakroun M, Zili J. Contact sensitization in atopic dermatitis: Results of a prospective study of 89 cases in Tunisia. Contact Dermat 2008; 58(3): 188-9. doi: 10.1111/j.1600-0536.2007.01248.x PMID: 18279174
  46. Thyssen JP, Linneberg A, Engkilde K, Menné T, Johansen JD. Contact sensitization to common haptens is associated with atopic dermatitis: New insight. Br J Dermatol 2012; 166(6): 1255-61. doi: 10.1111/j.1365-2133.2012.10852.x PMID: 22283138
  47. Malajian D, Belsito DV. Cutaneous delayed-type hypersensitivity in patients with atopic dermatitis. J Am Acad Dermatol 2013; 69(2): 232-7. doi: 10.1016/j.jaad.2013.03.012 PMID: 23583066
  48. Hamann CR, Hamann D, Egeberg A, Johansen JD, Silverberg J, Thyssen JP. Association between atopic dermatitis and contact sensitization: A systematic review and meta-analysis. J Am Acad Dermatol 2017; 77(1): 70-8. doi: 10.1016/j.jaad.2017.02.001 PMID: 28392290
  49. Chan CX, Zug KA. Diagnosis and Management of Dermatitis, Including Atopic, Contact, and Hand Eczemas. Med Clin North Am 2021; 105(4): 611-26. doi: 10.1016/j.mcna.2021.04.003 PMID: 34059241
  50. Brown C, Yu J. Pediatric Allergic Contact Dermatitis. Immunol Allergy Clin North Am 2021; 41(3): 393-408. doi: 10.1016/j.iac.2021.04.004 PMID: 34225896
  51. Schmidlin K, Sani S, Bernstein DI, Fonacier L. A hands-on approach to contact dermatitis and patch testing. J Allergy Clin Immunol Pract 2020; 8(6): 1883-93. doi: 10.1016/j.jaip.2020.02.009 PMID: 32112924
  52. Fonacier L. A Practical Guide to Patch Testing. J Allergy Clin Immunol Pract 2015; 3(5): 669-75. doi: 10.1016/j.jaip.2015.05.001 PMID: 26054552
  53. Fonacier L, Noor I. Contact dermatitis and patch testing for the allergist. Ann Allergy Asthma Immunol 2018; 120(6): 592-8. doi: 10.1016/j.anai.2018.03.003 PMID: 29522811
  54. Garg V, Brod B, Gaspari AA. Patch testing: Uses, systems, risks/benefits, and its role in managing the patient with contact dermatitis. Clin Dermatol 2021; 39(4): 580-90. doi: 10.1016/j.clindermatol.2021.03.005 PMID: 34809764
  55. Frings VG, Böer-Auer A, Breuer K. Histomorphology and immunophenotype of eczematous skin lesions revisited-skin biopsies are not reliable in differentiating allergic contact dermatitis, irritant contact dermatitis, and atopic dermatitis. Am J Dermatopathol 2018; 40(1): 7-16. doi: 10.1097/DAD.0000000000000842 PMID: 28296664
  56. Kadyk DL, McCarter K, Achen F, Belsito DV. Quality of life in patients with allergic contact dermatitis. J Am Acad Dermatol 2003; 49(6): 1037-48. doi: 10.1016/S0190-9622(03)02112-1 PMID: 14639382
  57. Hon KL, Chu S, Leung AKC. Quality of life for children with allergic skin diseases. Curr Pediatr Rev 2022; 18(3): 191-6. doi: 10.2174/1573396317666210901124211 PMID: 34488587
  58. Kiebert G, Sorensen SV, Revicki D, et al. Atopic dermatitis is associated with a decrement in health-related quality of life. Int J Dermatol 2002; 41(3): 151-8. doi: 10.1046/j.1365-4362.2002.01436.x PMID: 12010340
  59. Chren MM. The Skindex instruments to measure the effects of skin disease on quality of life. Dermatol Clin 2012; 30(2) 231-236, xiii. doi: 10.1016/j.det.2011.11.003 PMID: 22284137
  60. Kadyk DL, Hall S, Belsito DV. Quality of life of patients with allergic contact dermatitis: An exploratory analysis by gender, ethnicity, age, and occupation. Dermatitis 2004; 15(3): 117-24. doi: 10.2310/6620.2004.04007 PMID: 15724345
  61. Botto N, Raffi J, Trivedi M, Ramirez F, Allen IE, Chren MM. Validating a Quality-of-Life Instrument for Allergic Contact Dermatitis. Dermatitis 2019; 30(5): 300-5. doi: 10.1097/DER.0000000000000515 PMID: 31524758
  62. Raffi J, Elaine Allen I, Botto N. Validating Responsiveness of a Quality-of-Life Instrument for Allergic Contact Dermatitis. Dermatitis 2020; 31(3): 209-14. doi: 10.1097/DER.0000000000000542 PMID: 32049717
  63. Hon KL, Ng WGG, Kung JSC, Cheng NS, Ng DKK, Leung TF. Utility of the Pediatric Allergic Disease Quality of Life Questionnaire for childhood eczema. Br J Dermatol 2019; 181(2): 290-5. doi: 10.1111/bjd.17710 PMID: 30706447
  64. Nicholson PJ, Llewellyn D, English JS. Evidence-based guidelines for the prevention, identification and management of occupational contact dermatitis and urticaria. Contact Dermat 2010; 63(4): 177-86. doi: 10.1111/j.1600-0536.2010.01763.x PMID: 20831687
  65. Adisesh A, Robinson E, Nicholson PJ, Sen D, Wilkinson M. U.K. standards of care for occupational contact dermatitis and occupational contact urticaria. Br J Dermatol 2013; 168(6): 1167-75. doi: 10.1111/bjd.12256 PMID: 23374107
  66. Hon KL, Chu S, Leung AKC, Wong A. Atopic dermatitis: Conventional and integrative medicine. Curr Pediatr Rev 2022; 18(2): 84-96. doi: 10.2174/1573396317666210716152325 PMID: 34279204
  67. Hon KL, Leung AKC, Leung TNH, Lee VWY. Investigational drugs for atopic dermatitis. Expert Opin Investig Drugs 2018; 27(8): 637-47. doi: 10.1080/13543784.2018.1494723 PMID: 30058384
  68. Bhatia J, Sarin A, Wollina U, et al. Review of biologics in allergic contact dermatitis. Contact Dermat 2020; 83(3): 179-81. doi: 10.1111/cod.13584 PMID: 32347968
  69. Hogan DJ, Dannaker CJ, Maibach HI. The prognosis of contact dermatitis. J Am Acad Dermatol 1990; 23(2): 300-7. doi: 10.1016/0190-9622(90)70213-2 PMID: 2145326
  70. Hogan DJ, Dannaker CJ, Maibach HI, Lal S. An international survey on the prognosis of occupational contact dermatitis of the hands. Derm Beruf Umwelt 1990; 38(5): 143-7.
  71. Ibanez MA, Levoska MA, Zheng DX, Nedorost ST. Sodium metabisulfite allergic contact dermatitis from lidocaine exposure in an operating room nurse. Dermatitis 2021; 32(6): e108-9. doi: 10.1097/DER.0000000000000710 PMID: 34807534
  72. Tan MG, Li HO, Pratt MD. Systemic allergic dermatitis to sodium metabisulfite in local anesthetic solution. Contact Dermat 2022; 86(2): 120-1. doi: 10.1111/cod.13978 PMID: 34549447
  73. Hansel K, Sensini C, Caposciutti P, et al. Systemic allergic dermatitis during tetracaine hydrochloride patch testing. Contact Dermat 2021; 85(5): 596-8. doi: 10.1111/cod.13921 PMID: 34180549
  74. Pereira TM, Flour M, Goossens A. Allergic contact dermatitis from modified colophonium in wound dressings. Contact Dermat 2007; 56(1): 5-9. doi: 10.1111/j.1600-0536.2007.01026.x PMID: 17177702
  75. Traidl S, Werfel T, Ruëff F, Simon D, Lang C, Geier J. Patch test results in patients with suspected contact allergy to shoes: Retrospective IVDK data analysis 2009-2018. Contact Dermat 2021; 85(3): 297-306. doi: 10.1111/cod.13868 PMID: 33882155
  76. Lahouel I, Thabouti M, Belhadjali H, et al. Pustular allergic contact dermatitis caused by colophonium in depilatory wax. Contact Dermat 2021; 84(2): 130-2. doi: 10.1111/cod.13695 PMID: 32876340
  77. Tous-Romero F, Vico-Alonso C, Pinilla-Martín B, Ortiz de Frutos J. Allergic contact dermatitis from a depilatory wax. Contact Dermat 2020; 83(1): 65. doi: 10.1111/cod.13530
  78. Batchelor JM, Todd PM. Music and matrimony - hazards for the colophonium allergic patient. J R Soc Med 2010; 103(8): 332-4. doi: 10.1258/jrsm.2010.090418 PMID: 20610620
  79. Tan S, Tam MM, Nixon RL. Allergic contact dermatitis to Myroxylon pereirae (Balsam of Peru) in papaw ointment causing cheilitis. Australas J Dermatol 2011; 52(3): 222-3. doi: 10.1111/j.1440-0960.2011.00772.x PMID: 21834822
  80. de Groot AC. Myroxylon pereirae resin (balsam of Peru) - A critical review of the literature and assessment of the significance of positive patch test reactions and the usefulness of restrictive diets. Contact Dermat 2019; 80(6): 335-53. doi: 10.1111/cod.13263
  81. Turić P, Lipozencić J, Milavec-Puretić V, Kulisić SM. Contact allergy caused by fragrance mix and Myroxylon pereirae (balsam of Peru)--a retrospective study. Coll Antropol 2011; 35(1): 83-7.
  82. Guarneri F, Costa C, Cannavò SP, et al. Release of nickel and chromium in common foods during cooking in 18/10 (grade 316) stainless steel pots. Contact Dermat 2017; 76(1): 40-8. doi: 10.1111/cod.12692 PMID: 27804135
  83. Rodríguez-Jiménez P, Descalzo MA, Giménez Arnau AM, et al. Trend of relevant contact allergens of the feet in Spain over a period of 10 years. Contact Dermat 2020; 82(4): 211-7. doi: 10.1111/cod.13419 PMID: 31625171
  84. Admani S, Jacob SE. Allergic contact dermatitis in children: Review of the past decade. Curr Allergy Asthma Rep 2014; 14(4): 421. doi: 10.1007/s11882-014-0421-0 PMID: 24504525
  85. Goossens A, Aerts O. Contact allergy to and allergic contact dermatitis from formaldehyde and formaldehyde releasers: A clinical review and update. Contact Dermat 2022; 87(1): 20-7. doi: 10.1111/cod.14089 PMID: 35229319
  86. Reeder MJ. Allergic contact dermatitis to fragrances. Dermatol Clin 2020; 38(3): 371-7. doi: 10.1016/j.det.2020.02.009 PMID: 32475515
  87. Silverberg NB, Pelletier JL, Jacob SE, et al. Nickel allergic contact dermatitis: Identification, treatment, and prevention. Pediatrics 2020; 145(5)e20200628 doi: 10.1542/peds.2020-0628 PMID: 32341178
  88. Hayakawa M, Suzuki C, Zhu Y, Anzai H. Allergic contact dermatitis to gold in the parts of in‐ear headphones. Contact Dermat 2022; 86(4): 328-30. doi: 10.1111/cod.14036 PMID: 34978717
  89. Soriano LF, Chowdhury MMU, Cooper SM, et al. Current prevalence and relevance of positive patch test reactions to cosmetic and non-cosmetic isothiazolinones in the UK. Br J Dermatol 2021; 185(1): 223-5. doi: 10.1111/bjd.19898 PMID: 33657657
  90. Ito A, Suzuki K, Matsunaga K, et al. Patch testing with the J apanese baseline series 2015: A 4‐year experience. Contact Dermat 2022; 86(3): 189-95. doi: 10.1111/cod.14027 PMID: 34921568
  91. Mahajan V, Mehta K, Chauhan P, et al. Clinical, occupational and allergological profile of 455 patients with occupational contact dermatitis: A 5-year study from a tertiary care center of North India. Indian Dermatol Online J 2021; 12(4): 541-8. doi: 10.4103/idoj.IDOJ_768_20 PMID: 34430457
  92. Kamerud KL, Hobbie KA, Anderson KA. Stainless steel leaches nickel and chromium into foods during cooking. J Agric Food Chem 2013; 61(39): 9495-501. doi: 10.1021/jf402400v PMID: 23984718
  93. Jacob SE, Goldenberg A, Pelletier JL, Fonacier LS, Usatine R, Silverberg N. Nickel allergy and our children’s health: A review of indexed cases and a view of future prevention. Pediatr Dermatol 2015; 32(6): 779-85. doi: 10.1111/pde.12639 PMID: 26212605
  94. Draelos ZD. A clinical evaluation of a permanent hair dye designed to reduce allergic contact dermatitis and hair damage. J Cosmet Dermatol 2022; 21(9): 3925-8. doi: 10.1111/jocd.15212 PMID: 35790071
  95. Encabo Durán B, Romero-Pérez D, Silvestre Salvador JF. Allergic contact dermatitis due to Paraphenylenediamine: An update. Actas Dermo-Sifiliográficas 2018; 109(7): 602-9. doi: 10.1016/j.adengl.2018.06.017 PMID: 29496197
  96. Schubert S, Lessmann H, Schnuch A, Uter W, Geier J. Factors associated with p -phenylenediamine sensitization: Data from the Information Network of Departments of Dermatology, 2008-2013. Contact Dermat 2018; 78(3): 199-207. doi: 10.1111/cod.12920 PMID: 29322532
  97. Veverka KK, Hall MR, Yiannias JA, et al. Trends in patch testing with the mayo clinic standard series, 2011-2015. Dermatitis 2018; 29(6): 310-5. doi: 10.1097/DER.0000000000000411 PMID: 30422883
  98. Boffa MJ, Beck MH. Allergic contact dermatitis from quaternium 15 in Oilatum cream. Contact Dermat 1996; 35(1): 45-6. doi: 10.1111/j.1600-0536.1996.tb02265.x PMID: 8896954
  99. Tosti A, Maria Piraccini B, Bardazzo F. Occupational contact dermatitis due to quaternium 15. Contact Dermat 1990; 23(1): 41-2. doi: 10.1111/j.1600-0536.1990.tb00082.x PMID: 2144806
  100. Oborina RI, Kratasiuk VA. A biotest for determining human skin contamination by platinoids. Gig Tr Prof Zabol 1989; 12: 42-4.
  101. Roshchin AV, Veselov VG, Panova AI. Industrial toxicology of metals of the platinum group. J Hyg Epidemiol Microbiol Immunol 1984; 28(1): 17-24. PMID: 6715873
  102. Cristaudo A, Sera F, Severino V, De Rocco M, Di Lella E, Picardo M. Occupational hypersensitivity to metal salts, including platinum, in the secondary industry. Allergy 2005; 60(2): 159-64. doi: 10.1111/j.1398-9995.2004.00521.x PMID: 15647035
  103. Jiang Y, Wang S, Lyu J, Li J, Diao Q. Contact dermatitis associated with a cosmetic cream. J Cosmet Dermatol 2022; 21(10): 4479-81. doi: 10.1111/jocd.14847 PMID: 35156746
  104. Zhang AJ, Aschenbeck KA, Law BF. B’Hymer C, Siegel PD, Hylwa SA. Urushiol compounds detected in toxicodendron-labeled consumer products using mass spectrometry. Dermatitis 2020; 31(2): 134-9. doi: 10.1097/DER.0000000000000544 PMID: 32168145

Дополнительные файлы

Доп. файлы
Действие
1. JATS XML

© Bentham Science Publishers, 2024